Patents by Inventor Jean-Marc Rolain

Jean-Marc Rolain has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Automated method for analyzing and interpreting an antimicrobial susceptibility
    Patent number: 10837044
    Abstract: The present invention relates to a method of interpreting different antibiogram images in which it is possible to recognize a phenotype of bacterial resistance relative to antibiotics by comparing photographs using a photographic image bank of the reference antibiogram without any need to interpret them using the EUCAST or CA-SFM interpretation data; providing that for a given phenotype, there is available a collection of photographs of a plurality of bacteria of the same species and of the same phenotype.
    Type: Grant
    Filed: October 5, 2015
    Date of Patent: November 17, 2020
    Assignees: FONDATION MEDITERRANEE INFECTION, UNIVERSITE D'AIX MARSEILLE, ASSISTANCE PUBLIQUE—HOPITAUX DE MARSEILLE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE)
    Inventors: Jean-Marc Rolain, Didier Raoult, Stéphanie Le Page, Sylvain Buffet
  • AUTOMATED METHOD FOR ANALYZING AND INTERPRETING AN ANTIMICROBIAL SUSCEPTIBILITY
    Publication number: 20170298408
    Abstract: The present invention relates to a method of interpreting different antibiogram images in which it is possible to recognize a phenotype of bacterial resistance relative to antibiotics by comparing photographs using a photographic image bank of the reference antibiogram without any need to interpret them using the EUCAST or CA-SFM interpretation data; providing that for a given phenotype, there is available a collection of photographs of a plurality of bacteria of the same species and of the same phenotype.
    Type: Application
    Filed: October 5, 2015
    Publication date: October 19, 2017
    Applicants: FONDATION MEDITERRANEE INFECTION, UNIVERSITE D'AIX MARSEILLE, ASSISTANCE PUBLIQUE - HOPITAUX DE MARSEILLE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE),
    Inventors: Jean-Marc ROLAIN, Didier RAOULT, Stéphanie LE PAGE, Sylvain BUFFET
  • Use of squalamine or analogue as a disinfecting agent
    Patent number: 9700051
    Abstract: The present invention relates to the use of a compound chosen from squalamine and a squalamine-analog aminosteroid compound as agent for disinfecting an inert material object, in particular for the pre-disinfection of medical, dental, diagnostic or surgical equipment. The present invention also provides an aqueous or water-soluble disinfecting composition beneficial for a use according to the invention, characterized in that as disinfecting active compound it comprises a said antibacterial and antifungal compound selected from squalamine and a said squalamine-analog aminosteroid compound and suitable excipients for a water-soluble or aqueous formulation.
    Type: Grant
    Filed: January 4, 2013
    Date of Patent: July 11, 2017
    Assignees: ASSISTANCE PUBLIQUE—HOPITAUX DE MARSEILLE, UNIVERSITE D'AIX MARSEILLE, FONDATION MEDITERRANEE INFECTION
    Inventors: Jean-Michel Brunel, Didier Raoult, Jean-Marc Rolain
  • USE OF SQUALAMINE OR ANALOGUE AS A DISINFECTING AGENT
    Publication number: 20150005274
    Abstract: The present invention relates to the use of a compound chosen from squalamine and a squalamine-analogue aminosteroid compound as agent for disinfecting an inert material object, in particular for the pre-disinfection of medical, dental, diagnostic or surgical equipment. The present invention also provides an aqueous or water-soluble disinfecting composition beneficial for a use according to the invention, characterized in that as disinfecting active compound it comprises a said antibacterial and antifungal compound selected from squalamine and a said squalamine-analogue aminosteroid compound and suitable excipients for a water-soluble or aqueous formulation.
    Type: Application
    Filed: January 4, 2013
    Publication date: January 1, 2015
    Inventors: Jean-Michel Brunel, Didier Raoult, Jean-Marc Rolain